Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailComment je traite ... un herpès labial récurrent
Petit, L.; Braham, C.; Nikkels, Arjen ULg et al

in Information Dentaire (L') (2002), 22

L'herpès labial récurrent est une affection fréquente. Il fait suite à la réactivation du virus herpétique (HSV1 et au plus rarement HSV2) au niveau du ganglion de Gasser. Le traitement et la prévention ... [more ▼]

L'herpès labial récurrent est une affection fréquente. Il fait suite à la réactivation du virus herpétique (HSV1 et au plus rarement HSV2) au niveau du ganglion de Gasser. Le traitement et la prévention de l'herpès labial récurrent font classiquement appel à des agents antiviraux spécifiques. Les résultats spectaculaires obtenus chez les patients immunodéprimés sont beaucoup moins convaincants chez des sujets par ailleurs sains. D'autres voies prospectives de thérapeutique sont à l'étude utilisant des lipopeptides et des moyens physiques induisant une modification du pH cutané. [less ▲]

Detailed reference viewed: 82 (0 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... un lentigo malin par l'imiquimod topique (Aldara).
Bourguignon, Raphaël; Paquet, Philippe ULg; Quatresooz, Pascale ULg et al

in Revue Médicale de Liège (2005), 60(9), 691-4

Lentigo maligna is a special form of in situ cutaneous melanoma that develops on the face of sun worshipers. The topic immunostimulator imiquimod can destroy the neoplasm before it expresses its invasive ... [more ▼]

Lentigo maligna is a special form of in situ cutaneous melanoma that develops on the face of sun worshipers. The topic immunostimulator imiquimod can destroy the neoplasm before it expresses its invasive potential. A strict clinical follow-up of the treated zone must be observed at least 5 years to detect any early sign of recurrence. [less ▲]

Detailed reference viewed: 126 (3 ULg)
Full Text
See detailComment je traite ... un melasma du visage
Pierard, Gérald ULg

in Revue Médicale de Liège (1997), 52(2), 58-9

Detailed reference viewed: 11 (0 ULg)
Peer Reviewed
See detailComment je traite ... un patient avec une insuffisance cardiaque légère ou modérée?
Pierard, Luc ULg

in Revue Médicale de Liège (1995), 50(1), 5-6

Detailed reference viewed: 10 (0 ULg)
Full Text
See detailComment je traite ... un phénomène de Raynaud
Pierard, Gérald ULg

in Revue Médicale de Liège (1998), 53(3), 119-20

Raynaud's phenomenon is a paroxysmal vasospasm affecting the extremities, particularly the fingers. The idiopathic type is the most frequently encountered and the secondary types have multiple origins ... [more ▼]

Raynaud's phenomenon is a paroxysmal vasospasm affecting the extremities, particularly the fingers. The idiopathic type is the most frequently encountered and the secondary types have multiple origins. The mainstay of treatment relies on hygieno-dietetic measures. When they fail, calcium antagonists, sustained-release transdermal glyceryl trinitrate and a few other vasoactive drugs may prove to be effective. However, side effects may limit their prescription. [less ▲]

Detailed reference viewed: 20 (0 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... un psoriasis en plaques par l'association calcipotriol-dipropionate de betamethasone.
Henry, Frédérique ULg; Flagothier, Caroline ULg; Franchimont, Claudine ULg et al

in Revue Médicale de Liège (2006), 61(3), 139-41

The combination of calcipotriol and betamethasone dipropionate in a single topical formulation is a recent advance in treatment of plaque type psoriasis. Studies rooted on evidence-based medicine have ... [more ▼]

The combination of calcipotriol and betamethasone dipropionate in a single topical formulation is a recent advance in treatment of plaque type psoriasis. Studies rooted on evidence-based medicine have been recently published. We report a synthesis and a critical analysis, critical analysis of these investigations, and translate their data with a view to apply them in daily practice. [less ▲]

Detailed reference viewed: 68 (1 ULg)
Peer Reviewed
See detailComment je traite ... Un sujet a risque d'endocardite infectieuse
Kulbertus, Henri ULg; Pierard, Luc ULg

in Revue Médicale de Liège (1997), 52(5), 316

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailCOMMENT JE TRAITE ... une colique néphrétique.
Lavergne, O.; Bonnet, Quentin; Thomas, Alexandre et al

in Revue Médicale de Liège (2016), 71(5), 220-6

Renal colic (RC) represents nearly 2% of emergency department admissions. RC is defined by the occurrence of back pain which may radiate towards the abdomen and external genitals. In adults, the ... [more ▼]

Renal colic (RC) represents nearly 2% of emergency department admissions. RC is defined by the occurrence of back pain which may radiate towards the abdomen and external genitals. In adults, the obstruction is caused by a urinary stone in 80% of cases. The 20 % of non-stone related RCs are due either to an intrinsic obstruction (pyeloureteral junction stenosis, ureteral tumor, ...) or an extrinsic compression (pelvic tumor, lymphadenopathy ...). In over 90% of cases, an RC does not require hospitalization and is treated with medication. In contrast, complicated renal colic (CRC) requires hospitalization with specialized care. Obstructive pyelonephritis (OPN) is a form of CRC and the diagnosis should be considered in a clinical presentation of "renal colic" with acute pyelonephritis. This is a true emergency requiring surgical drainage of the upper urinary tract upstream of the obstacle, as well as antibiotic therapy. It must be kept in mind that some clinical presentations may be atypical, especially in the elderly, which can delay the diagnosis and, thus, the management. The gold standard for diagnosis is CT urography. [less ▲]

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une dermatite seborrhéique.
Pierard, Claudine ULg; Arrese Estrada, Jorge ULg; Pierard, Gérald ULg

in Revue Médicale de Liège (2003), 58(2), 67-9

Seborrhoeic dermatitis results from a peculiar inflammatory reaction directed to yeasts of the genus Malassezia which are present at the skin surface. The current therapeutic strategies to control ... [more ▼]

Seborrhoeic dermatitis results from a peculiar inflammatory reaction directed to yeasts of the genus Malassezia which are present at the skin surface. The current therapeutic strategies to control episodes of the dermatitis target the yeasts, the host reaction or both. [less ▲]

Detailed reference viewed: 230 (4 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une dyslipidemie en fonction du profil de risque cardiovasculaire.
Descamps, O. S.; SCHEEN, André ULg; De Backer, G. et al

in Revue Médicale de Liège (2012), 67(4), 167-73

The new guidelines from the European Atherosclerosis Society and the European Society of Cardiology include a number of new items. Here we demonstrate their application in several different clinical ... [more ▼]

The new guidelines from the European Atherosclerosis Society and the European Society of Cardiology include a number of new items. Here we demonstrate their application in several different clinical examples. We focus on the 4 items most pertinent for medical practice: 1) the stratification of risk of cardiovascular disease into 4 categories ('very high', 'high', 'moderate' and 'low risk'), involving--for primary prevention cases--the use of the SCORE table, which has been calibrated for Belgium and where the risk can be adjusted according to HDL cholesterol and the presence of other risk factors; 2) the choice of more stringent therapeutic targets for LDL cholesterol (< 70 mg/dl for 'very high' risk patients, 100 mg/dl for 'high' risk patients and 115 mg/dl for patients at 'moderate' risk); 3) the choice of other therapeutic targets (non-HDL cholesterol and apolipoprotein B levels) for patients at 'very high' or 'high' risk with combined dyslipidaemia; and 4) follow-up of lipid parameters and muscular and hepatic enzymatic profiles. [less ▲]

Detailed reference viewed: 142 (4 ULg)
Full Text
See detailComment je traite ... une epilepsie refractaire par stimulation du nerf vague
Sadzot, Bernard ULg; Martin, Didier ULg

in Revue Médicale de Liège (2001), 56(6), 407-10

Intermittent left vagus nerve stimulation is a novel therapeutic modality that can be proposed to patients with a refractory epilepsy and for whom resective surgery is not an option. Its precise mechanism ... [more ▼]

Intermittent left vagus nerve stimulation is a novel therapeutic modality that can be proposed to patients with a refractory epilepsy and for whom resective surgery is not an option. Its precise mechanism of action is not known. Controlled studies have shown that its efficacy is similar to that of antiepileptic drugs: 50% decrease in seizure frequency in 40% patients after two years. Side effects which are generally mild to moderate are the result of a diffusion of the stimulation to the larynx. No CNS side effect has been reported. [less ▲]

Detailed reference viewed: 172 (10 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une grossesse extra-uterine
Degee, S.; Dricot, J. F.; Lamborelle, S. et al

in Revue Médicale de Liège (2006), 61(12), 797-803

Nowadays, the management of ectopic pregnancy should be codified as often as possible. Two types of treatment are possible. One surgical and the other medical. Our study is concerned with a series of 97 ... [more ▼]

Nowadays, the management of ectopic pregnancy should be codified as often as possible. Two types of treatment are possible. One surgical and the other medical. Our study is concerned with a series of 97 patients hospitalized for suspicion of ectopic pregnancy for whom the risk factors and treatment were analyzed. Our conclusion is that the medical treatment should be more frequently proposed and surgery should prefer the conservative treatment whenever it is still possible. [less ▲]

Detailed reference viewed: 159 (14 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une hypertrichose.
Pierard, Claudine ULg; Henry, Frédérique ULg; Paquet, Philippe ULg et al

in Revue Médicale de Liège (2003), 58(10), 605-10

Hypertrichosis can result from various origins and exhibit diverse clinical presentations. Any etiological treatment, when available, does not always lead to regression of the excess in pilosity. Most ... [more ▼]

Hypertrichosis can result from various origins and exhibit diverse clinical presentations. Any etiological treatment, when available, does not always lead to regression of the excess in pilosity. Most often, hypertrichosis represents a real esthetic burden and affects the patient's self-esteem. Currently the laser epilation technique offers new and promising therapeutic possibilities. [less ▲]

Detailed reference viewed: 169 (2 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une hypoglycemie grave chez un patient diabetique.
Radermecker, Régis ULg; Philips, Jean-Christophe ULg; Scheen, André ULg

in Revue Médicale de Liège (2003), 58(3), 119-22

Severe hypoglycaemic episodes are defined as need of assistance and may progress to profound coma. They can occur in patients treated with insulin, generally for type 1 diabetes, or in patients receiving ... [more ▼]

Severe hypoglycaemic episodes are defined as need of assistance and may progress to profound coma. They can occur in patients treated with insulin, generally for type 1 diabetes, or in patients receiving sulphonylureas, for type 2 diabetes. Diagnosis is usually obvious, at least in insulin-treated patients, and requires an urgent intervention from the entourage. Such an intervention should comprise the oral administration of carbohydrates with high-glycaemic index if consciousness allows it or, if not, the injection of glucagon. When necessary, people should ask the help of a physician who will inject hypertonic glucose intravenously. Hypoglycaemic coma related to an absolute or relative excess of insulin should, in most cases, be treated at home. In contrast, a hypoglycaemic coma due to a too high dosage of sulphonylurea always requests a hospitalisation in order to carefully supervise the patient and to provide a prolonged intravenous infusion of glucose. It is mandatory that family or entourage members of any diabetic patient at risk to develop severe hypoglycaemia receive a specific education in order to promptly apply the best treatment capable of a rapid and safe recovery from hypoglycaemic coma. [less ▲]

Detailed reference viewed: 194 (5 ULg)
Peer Reviewed
See detailComment je traite ... une infection par le VIH. I. Bases pathogéniques des choix thérapeutiques
Moutschen, Michel ULg; Nkoghe, D.; Leonard, Philippe ULg et al

in Revue Médicale de Liège (1997), 52(10), 622-4

Detailed reference viewed: 19 (1 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une mucoviscidose
BENDAVID, G.; VANDERHELST, E.; LOUIS, Renaud ULg et al

in Revue Médicale de Liège (2015), 70(3), 108-114

Detailed reference viewed: 53 (5 ULg)
Peer Reviewed
See detailComment je traite ... une obesite severe et ses anomalies metaboliques par une gastroplastie.
Luyckx, Françoise ULg; Scheen, André ULg; Letiexhe, Michel ULg et al

in Revue Médicale de Liège (1999), 54(3), 138-42

Severe obesity, defined as a body mass index > or = 35 kg/m2, is frequently associated with various biological abnormalities, particularly in the presence of intra-abdominal adiposity. The most important ... [more ▼]

Severe obesity, defined as a body mass index > or = 35 kg/m2, is frequently associated with various biological abnormalities, particularly in the presence of intra-abdominal adiposity. The most important disorders belong to the so-called insulin resistance syndrome, metabolic syndrome or syndrome X: hyperinsulinaemia, impaired glucose tolerance or type 2 diabetes, dyslipidaemias, hyperuricaemia, hyperfibrinogenaemia. All these metabolic abnormalities are considered as cardiovascular risk factors. They are also correlated with the severity of the liver steatosis which is commonly observed in individuals with severe obesity. We report our experience of the evolution of these metabolic abnormalities after a marked weight loss induced by gastroplasty. We will analyse the favourable effects of bariatric surgery on insulin sensitivity, biological components of the metabolic syndrome, type 2 diabetes and liver steatosis. [less ▲]

Detailed reference viewed: 62 (3 ULg)
Full Text
See detailComment je traite ... une onychomycose par thérapie pulsée
Pierard, Gérald ULg

in Revue Médicale de Liège (1997), 52(6), 379-81

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detailComment je traite ... une polyarthrite rhumatoïde. L'avènement d'une nouvelle ère thérapeutique: les anticorps anti-TNF-alpha
Kaiser, Marie-Joëlle ULg; Malaise, Michel ULg

in Revue Médicale de Liège (2002), 57(8), 486-492

Rheumatoid arthritis (RA) is the most frequent autoimmune inflammatory arthropathy. Chronic synovial inflammation usually results in cartilage destruction, bone erosion and subsequent joint deformities ... [more ▼]

Rheumatoid arthritis (RA) is the most frequent autoimmune inflammatory arthropathy. Chronic synovial inflammation usually results in cartilage destruction, bone erosion and subsequent joint deformities with impaired physical function. These consequences are more or less delayed by standard disease-modifying antirheumatic drugs (DMARDs). A better knowledge of the basic mechanisms of the disease and new biomolecular tools led to the development of novel biological agents including TNF alpha blockers. TNF alpha is a key inflammatory cytokine that plays a critically important role in the pathogenesis of RA. TNF alpha blockers brought dramatic improvements in efficacy of RA treatment. Here we will review the pathophysiological elements of RA wich explain the therapeutic efficacy of these TNF alpha blockers and we will describe in details the molecules, Remicade (Infliximab) and Enbrel (Etanercept), wich will be very soon used in daily practice in Belgium. [less ▲]

Detailed reference viewed: 126 (6 ULg)
Full Text
Peer Reviewed
See detailComment je traite ....... Le delirium chez le patient âgé
CHRISTELBACH, Sophie ULg; ALLEPAERTS, Sophie ULg; PETERMANS, Jean ULg

in Revue Médicale de Liège (2016)

Detailed reference viewed: 32 (10 ULg)